A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

Clinical trial NCT05121480 · COMPLETED

Trial details

NCT number: NCT05121480
Sponsor: Evelo Biosciences, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-01-31
Primary completion: 2023-03-09
Enrollment: 421

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.